HLA, CTLA-4 and PTPN22: The shared genetic master-key to autoimmunity?

Expert Reviews in Molecular Medicine

Volumn 7, Issue 23, 2005, Pages 1-15

  Brand, Oliver ^a   Gough, Stephen ^a   Heward, Joanne ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 2; PROTEIN TYROSINE PHOSPHATASE;

ADDISON DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME 1P; CHROMOSOME 2Q; CHROMOSOME 6P; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HUMAN; HYPOTHESIS; HYPOTHYROIDISM; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 31044438675     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399405009981     Document Type: Review

References (85)

1. Vyse, T.J. and Todd, J.A. (1996) Genetic analysis of autoimmune disease. Cell 85, 311-318, PubMed: 8616887
2. Heward, J. and Gough, S.C. (1997) Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond) 93, 479-491, PubMed: 9497784
3. Becker, K.G. (1999) Comparative genetics of type 1 diabetes and autoimmune disease: Common loci, common pathways? Diabetes 48, 1353-1358, PubMed: 10389838
4. Vyse, T.J. and Kotzin, B.L. (1998) Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 16, 261-292, PubMed: 9597131
5. Tait, K.F. et al. (2004) Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository. Diabet Med 21, 358-362, PubMed: 15049939
6. Awata, T. et al. (1992) Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35, 419-424, PubMed: 1521722
7. Badenhoop, K. et al. (1995) Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80, 2112-2117, PubMed: 7608264
8. Simmonds, M.J. et al. (2005) Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76, 157-163, PubMed: 15558498
9. Ueda, H. et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511, PubMed: 12724780
10. Vaidya, B. et al. (1999) The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8, 1195-1199, PubMed: 10369864
11. Bottini, N. et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36, 337-338, PubMed: 15004560
12. Smyth, D. et al. (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53, 3020-3023, PubMed: 15504986
13. Onengut-Gumuscu, S. et al. (2004) A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families. Genes Immun 5, 678-680, PubMed: 15526003
14. Criswell, L.A. et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76, 561-571, PubMed: 15719322
15. Ladner, M.B. et al. (2005) Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 66, 60-64, PubMed: 15620463
16. Velaga, M.R. et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89, 5862-5865, PubMed: 15531553
17. Kyogoku, C. et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75, 504-507, PubMed: 15273934
18. Orozco, G. et al. (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52, 219-224, PubMed: 15641066
19. Begovich, A.B. et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75, 330-337, PubMed: 15208781
20. Lee, A.T. et al. (2005) The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 6, 129-133, PubMed: 15674368
21. Sprent, J. and Kishimoto, H. (2001) The thymus and central tolerance. Transplantation 72, S25-28, PubMed: 11888152
22. Wucherpfennig, K.W. (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108, 1097-1104, PubMed: 11602615
23. Walker, L.S. and Abbas, A.K. (2002) The enemy within: Keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2, 11-19, PubMed: 11908514
24. Simmonds, M.J. and Gough, S.C. (2004) Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 71, 93-113, PubMed: 15701924
25. Shevach, E.M. (2000) Regulatory T cells in autoimmmunity*. Annu Rev Immunol 18, 423-449, PubMed: 10837065
26. Nerup, J. et al. (1974) HL-A antigens and diabetes mellitus. Lancet 2, 864-866, PubMed: 4137711
27. Giordano, M., D'Alfonso, S. and Momigliano-Richiardi, P. (2002) Genetics of multiple sclerosis: Linkage and association studies. Am J Pharmacogenomics 2, 37-58, PubMed: 12083953
28. Newton, J.L. et al. (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5, 151-157, PubMed: 14749714
29. Heward, J.M. et al. (1998) Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: Replication using a population case control and family-based study. J Clin Endocrinol Metab 83, 3394-3397, PubMed: 9768636
30. Weetman, A.P. et al. (1991) HLA associations with autoimmune Addison's disease. Tissue Antigens 38, 31-33, PubMed: 1926131
31. Simmonds, M.J. and Gough, S.C. (2004) Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 136, 1-10, PubMed: 15030506
32. Graham, R.R. et al. (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71, 543-553, PubMed: 12145745
33. Todd, J.A., Bell, J.I. and McDevitt, H.O. (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599-604, PubMed: 3309680
34. Ban, Y. et al. (2004) Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 5, 203-208, PubMed: 15029234
35. Cucca, F. et al. (1993) Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 37, 85-94, PubMed: 8226139
36. Cucca, F. et al. (1995) The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol 43, 301-308, PubMed: 7499178
37. Gregersen, P.K., Silver, J. and Winchester, R.J. (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30, 1205-1213, PubMed: 2446635
38. de Vries, N. et al. (2002) Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum 46, 921-928, PubMed: 11953968
39. Jorgensen, J.L. et al. (1992) Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355, 224-230, PubMed: 1309938
40. Kurata, A. and Berzofsky, J.A. (1990) Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule? J Immunol 144, 4526-4535, PubMed: 2141038
41. Bhayani, H. and Paterson, Y. (1989) Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations. J Exp Med 170, 1609-1625, PubMed: 2553848
42. Cucca, F. et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10, 2025-2037, PubMed: 11590120
43. Nanda, N.K. et al. (1995) Recognition of multiple peptide cores by a single T cell receptor. J Exp Med 182, 531-539, PubMed: 7629510
44. Kwok, W.W. et al. (1990) Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition. J Exp Med 171, 85-95, PubMed: 2104922
45. Stern, L.J. et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221, PubMed: 8145819
46. Nepom, G.T. et al. (1996) Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions. Eur J Immunol 26, 949-952, PubMed: 8625994
47. Nepom, G.T. and Kwok, W.W. (1998) Molecular basis for HLA-DQ associations with IDDM. Diabetes 47, 1177-1184, PubMed: 9703314
48. Nepom, G.T. (1990) A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39, 1153-1157, PubMed: 2210067
49. Egen, J.G., Kuhns, M.S. and Allison, J.P. (2002) CTLA-4: New insights into its biological function and use in tumor immunotherapy. Nat Immunol 3, 611-618, PubMed: 12087419
50. Mueller, D.L., Jenkins, M.K. and Schwartz, R.H. (1989) Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7, 445-480, PubMed: 2653373
51. Heward, J.M. et al. (1999) The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 84, 2398-2401, PubMed: 10404810
52. Nistico, L. et al. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5, 1075-1080, PubMed: 8817351
53. Nithiyananthan, R. et al. (2002) Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12, 3-6, PubMed: 11842815
54. Vaidya, B. et al. (2000) Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulators (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 85, 688-691, PubMed: 10690877
55. Blomhoff, A. et al. (2004) Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89, 3474-3476, PubMed: 15240634
56. Vijayakrishnan, L. et al. (2004) An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20, 563-575, PubMed: 15142525
57. Egen, J.G. and Allison, J.P. (2002) Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35, PubMed: 11825563
58. Alegre, M.L. et al. (1996) Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157, 4762-4770, PubMed: 8943377
59. Finn, P.W. et al. (1997) Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J Immunol 158, 4074-4081, PubMed: 9126965
60. Marengere, L.E. et al. (1996) Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170-1173, PubMed: 8638161
61. Masteller, E.L. et al. (2000) Structural analysis of CTLA-4 function in vivo. J Immunol 164, 5319-5327, PubMed: 10799894
62. Cloutier, J.F. and Veillette, A. (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189, 111-121, PubMed: 9874568
63. Lee, K.M. et al. (1998) Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263-2266, PubMed: 9856951
64. LO, D. et al. (2004) Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol 173, 7135-7139, PubMed: 15585834
65. Duan, L. et al. (2004) The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity 21, 7-17, PubMed: 15345216
66. Bachmaier, K. et al. (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216, PubMed: 10646608
67. Yokoi, N. et al. (2002) Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 31, 391-394, PubMed: 12118252
68. Mustelin, T. et al. (2004) Protein tyrosine phosphatases in T cell physiology. Mol Immunol 41, 687-700, PubMed: 15220004
69. Cohen, S. et al. (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93, 2013-2024, PubMed: 10068674
70. Gjorloff-Wingren, A. et al. (2000) Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur J Immunol 30, 2412-2421, PubMed: 10940933
71. Hill, R.J. et al. (2002) The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 30, 237-244, PubMed: 11882361
72. Viken, M.K. et al. (2005) Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6, 271-273, PubMed: 15759012
73. Begovich, A.B. et al. (2005) The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 76, 184-187, PubMed: 15580548
74. Matesanz, F. et al. (2005) Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol PubMed: 15765267
75. Chow, L.M. and Veillette, A. (1995) The Src and Csk families of tyrosine protein kinases in hemopoietic cells. Semin Immunol 7, 207-226, PubMed: 8520026
76. Chow, L.M. et al. (1993) Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature 365, 156-160, PubMed: 8371758
77. Schmedt, C. et al. (1998) Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature 394, 901-904, PubMed: 9732874
78. Ghose, R. et al. (2001) A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat Struct Biol 8, 998-1004, PubMed: 11685249
79. Gjorloff-Wingren, A. et al. (1999) Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol 29, 3845-3854, PubMed: 10601992
80. Ota, Y. and Samelson, L.E. (1997) The product of the proto-oncogene c-cbl: A negative regulator of the Syk tyrosine kinase. Science 276, 418-420, PubMed: 9103201
81. Lupher, M.L., Jr. et al. (1997) The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem 272, 33140-33144, PubMed: 9407100
82. Feshchenko, E.A., Langdon, W.Y. and Tsygankov, A.Y. (1998) Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J Biol Chem 273, 8323-8331, PubMed: 9525940
83. Schneider, H. et al. (1995) T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras. Eur J Immunol 25, 1044-1050, PubMed: 7737275
84. Kim, H.H., Tharayil, M. and Rudd, C.E. (1998) Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J Biol Chem 273, 296-301, PubMed: 9417079
85. Okkenhaug, K. and Rottapel, R. (1998) Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J Biol Chem 273, 21194-21202, PubMed: 9694876